Kilitch Drugs India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on July 11, 2008, inter alia, has transacted the following business:
1. The Board has decided to issue, subject to all the relevant approvals, as well as in compliance of the Guidelines for Preferential Issues of Chapter XIII of the SEBI (DIP) Guidelines, 2000, an aggregate of 29 lac convertible warrants (one Warrant being convertible into one equity share) in favour of select entities, including promoters. The price for the issue of these Warrants is to be worked out in terms of the SEBI Guidelines in this regard.
2. The Board has decided to call an Extra Ordinary General Meeting of the shareholders, on August 11, 2008, for seeking their approval to the proposed issue of the Warrants.
1. The Board has decided to issue, subject to all the relevant approvals, as well as in compliance of the Guidelines for Preferential Issues of Chapter XIII of the SEBI (DIP) Guidelines, 2000, an aggregate of 29 lac convertible warrants (one Warrant being convertible into one equity share) in favour of select entities, including promoters. The price for the issue of these Warrants is to be worked out in terms of the SEBI Guidelines in this regard.
2. The Board has decided to call an Extra Ordinary General Meeting of the shareholders, on August 11, 2008, for seeking their approval to the proposed issue of the Warrants.
No comments:
Post a Comment